Katherine Levy
Apr 14, 2011

Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

Novatris currently works with incumbent MEC
Novatris currently works with incumbent MEC

WPP's MEC is the incumbent on the global business.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

This article was first published on campaignlive.co.uk.

Source:
Campaign Asia

Related Articles

Just Published

5 hours ago

Cision CEO Cali Tran takes a new role

Tran has moved to the position of chairman at Cision, which is searching for a permanent replacement.

5 hours ago

Pinterest warns of year-end ad slowdown in Q3 earnings

Shares in the social media company slumped following the announcement, despite strong user numbers and top- and bottom-line growth.

5 hours ago

Brands and brand leaders react to Trump’s presidenti...

Many company leaders congratulated Donald Trump on becoming the next US President-elect, while some are expressing heartbreak.

2 days ago

The return of Donald Trump: What it means for ...

As Donald Trump secures his second term as US president, marketing leaders across APAC weigh in on the potential impact on regional business, brand spend, and industry growth in a volatile economic landscape.